Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,674
Total Claims
$1.9M
Drug Cost
823
Beneficiaries
$2,283
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-69%
Opioid rate vs peers
0.7% vs 2.2% avg
+62%
Cost per patient vs peers
$2,283 vs $1,411 avg
+67%
Brand preference vs peers
17.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
131
Opioid Claims
$3,447
Opioid Cost
27.5%
Long-Acting Rate
Brand vs Generic
Brand: 3,305 claims · $1.3M
Generic: 15,273 claims · $605K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 758 | $234K |
| Collagenase Clostridium Hist. | 114 | $119K |
| Sitagliptin Phosphate | 340 | $96K |
| Rifaximin | 23 | $47K |
| Rivaroxaban | 161 | $45K |
| Insulin Aspart | 123 | $36K |
| Sacubitril/Valsartan | 81 | $32K |
| Sodium Zirconium Cyclosilicate | 33 | $28K |
| Linagliptin | 95 | $27K |
| Memantine Hcl | 413 | $27K |
| Dapagliflozin Propanediol | 70 | $21K |
| Sitagliptin Phos/Metformin Hcl | 80 | $21K |
| Semaglutide | 21 | $21K |
| Dulaglutide | 19 | $19K |
| Fluticasone/Vilanterol | 48 | $18K |
Prescribing Profile
Patient Profile
77
Avg Age
58%
Female
2.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About